Submitted:
15 July 2024
Posted:
16 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Overview of Vaccine Hesitancy:
- -
- Factors affecting Vaccine Hesitancy
- -
- Existing Communication Strategies:
3. Understanding Vaccine Hesitancy:
- -
- Factors that contribute to vaccine hesitancy:
- -
- Impact of Vaccine Hesitancy:
4. Effective Communication Strategies
- -
-
Present evidence-based communication strategies for addressing vaccine hesitancy:
- Building Trust: Establishing trust is essential in communicating with individuals who are hesitant about vaccines. Healthcare providers, public health officials, and community leaders should engage with the community, listen to their concerns, and empathize with their perspectives. This can help build rapport and credibility, making individuals more receptive to receiving accurate information about vaccines [32].
- Providing Accurate Information: Providing evidence-based, accurate information about vaccines is crucial in dispelling myths and misconceptions. Tailoring information to the specific concerns of individuals or communities can help increase understanding and address any doubts they may have. Utilizing plain language, visuals, and multimedia tools can also enhance comprehension and engagement [33,34].
- Addressing Myths and Misconceptions: Vaccine hesitancy is often fueled by misinformation and myths circulating in communities. Addressing these myths proactively and transparently can help in countering false narratives. Communicating the safety and effectiveness of vaccines, highlighting the rigorous testing and regulatory processes vaccines undergo, and debunking common misconceptions can help alleviate concerns and increase confidence in vaccination [35].
- Engaging with Local Influencers: Engaging with trusted local influencers, such as community leaders, religious figures, and healthcare professionals, can help in disseminating accurate information and promoting vaccine acceptance. Collaborating with these influencers to address concerns, answer questions, and endorse vaccination can leverage their credibility and reach within the community [36].
- Utilizing social media and Digital Platforms: Leveraging social media and digital platforms to disseminate accurate information, counter misinformation, and engage with individuals hesitant about vaccines can be effective. Developing targeted campaigns, utilizing data-driven strategies, and actively monitoring and addressing misinformation online can help in reaching a wider audience and fostering open dialogue [24].
- -
- Discuss the role of healthcare providers, public health officials, and community leaders in promoting vaccination
5. Case Studies
- Public Health Messaging in Great Britain (England, Scotland and Wales): In Great Britain (England, Scotland and Wales), public health authorities successfully used a combination of traditional media, social media, and community outreach to address vaccine hesitancy during the COVID-19 pandemic. Messages focused on the safety and efficacy of vaccines, as well as the importance of vaccination in protecting individuals and communities [37].
- Personal Stories in the United States: In the United States, organizations such as the Vaccinate Your Family campaign have effectively used personal stories and testimonials to combat vaccine hesitancy. By sharing the experiences of individuals who have been personally affected by vaccine-preventable diseases, these campaigns have helped to humanize the issue and emphasize the importance of vaccination [38].
- Community Engagement in Nigeria: In Nigeria, community engagement strategies have been used to address vaccine hesitancy in remote and marginalized populations. By working closely with community leaders, healthcare providers, and local organizations, public health authorities have been able to build trust and rapport with communities, leading to increased vaccine acceptance [39].
- Vaccine Clinics in the United States: In the USA, mobile vaccine clinics have been established in underserved communities to improve access to vaccines and address vaccine hesitancy. By bringing vaccines directly to communities, public health authorities have been able to reach individuals who may not have otherwise had access to vaccination services, leading to higher vaccination rates [40].
6. Recommendations
- i.
-
Healthcare providers:
- -
- Take the time to listen to the concerns and questions of vaccine-hesitant individuals, and provide accurate and evidence-based information to address their specific concerns.
- -
- Use clear and accessible language when discussing vaccines, avoiding jargon or overly technical explanations.
- -
- Incorporate shared decision-making approaches to involve vaccine-hesitant individuals in the decision-making process and tailor recommendations to their individual values and preferences.
- -
- Emphasize the importance of vaccines in protecting not only the individual but also the community from preventable diseases.
- ii.
-
Public health officials:
- -
- Develop targeted communication campaigns that address common misconceptions and concerns about vaccines, using diverse platforms to reach different populations.
- -
- Collaborate with community leaders and trusted influencers to disseminate accurate information and address misinformation.
- -
- Provide transparent and timely updates on vaccine safety and effectiveness, addressing any emerging issues or concerns.
- -
- Highlight the benefits of vaccination in preventing outbreaks and protecting vulnerable populations, framing vaccines as a public good.
- iii.
-
Policymakers:
- -
- Support policies that promote vaccination uptake, such as mandating vaccines for certain populations or providing incentives for vaccination.
- -
- Allocate resources for education and outreach programs aimed at addressing vaccine hesitancy and improving vaccine confidence.
- -
- Invest in research to better understand the underlying factors contributing to vaccine hesitancy and develop tailored communication strategies.
- -
- Engage with stakeholders, including healthcare providers, public health officials, and community groups, to develop collaborative approaches to address vaccine hesitancy at the local and national levels.
7. Conclusions
References
- New data shows vaccines have saved 154 million lives in the past 50 years. (2024, May 27). https://www.gavi.org/vaccineswork/new-data-shows-vaccines-have-saved-154-million-lives-past-50-years.
- Vaccine Hesitancy - University of Pittsburgh Press. (2024, June 18). University of Pittsburgh Press. https://upittpress.org/books/9780822966906/.
- Nuwarda, R.F.; Ramzan, I.; Weekes, L.; Kayser, V. (2022). Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines, 10(10), 1595. [CrossRef]
- Zimmerman, T.; Shiroma, K.; Fleischmann, K.R.; Xie, B.; Jia, C.; Verma, N.; Lee, M.K. (2023). Misinformation and COVID-19 vaccine hesitancy. Vaccine, 41(1), 136–144. [CrossRef]
- Avelino-Silva, V.I.; Ferreira-Silva, S.N.; Soares ME, M.; Vasconcelos, R.; Fujita, L.; Medeiros, T.; Barbieri CL, A.; Couto, M.T. (2023). Say it right: measuring the impact of different communication strategies on the decision to get vaccinated. BMC Public Health, 23(1). [CrossRef]
- McCready, J.L.; Nichol, B.; Steen, M.; Unsworth, J.; Comparcini, D.; Tomietto, M. (2023). Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review. PloS One, 18(4), e0280439. [CrossRef]
- Cascini, F.; Pantovic, A.; Al-Ajlouni, Y.A.; Failla, G.; Puleo, V.; Melnyk, A.; Lontano, A.; Ricciardi, W. (2022). Social media and attitudes towards a COVID-19 vaccination: A systematic review of the literature. EClinicalMedicine, 48, 101454. [CrossRef]
- Sinuraya, R.K.; Nuwarda, R.F.; Postma, M.J.; Suwantika, A.A. (2024). Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia. Globalization and Health, 20(1). [CrossRef]
- Nazlı, E.B.; Yığman, F.; Sevindik, M.; Özturan, D.D. (2021). Psychological factors affecting COVID-19 vaccine hesitancy. Irish Journal of Medical Science, 191(1), 71–80. [CrossRef]
- Volet, A.K.; Scavone, C.; Catalán-Matamoros, D.; Capuano, A. (2022). Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust. Frontiers in Public Health, 10. [CrossRef]
- Lee, J.; Huang, Y. (2022). COVID-19 Vaccine Hesitancy: The Role of Socioeconomic Factors and Spatial Effects. Vaccines, 10(3), 352. [CrossRef]
- Larson, H.J.; Lin, L. (2024). Generative artificial intelligence can have a role in combating vaccine hesitancy. BMJ, q69. [CrossRef]
- Ruggeri, K.; Vanderslott, S.; Yamada, Y.; Argyris, Y.A.; Većkalov, B.; Boggio, P.S.; Fallah, M.P.; Stock, F.; Hertwig, R. (2024). Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media. BMJ, e076542. [CrossRef]
- Leonardelli, M.; Mele, F.; Marrone, M.; Germinario, C.A.; Tafuri, S.; Moscara, L.; Bianchi, F.P.; Stefanizzi, P. (2023). The Effects of the COVID-19 Pandemic on Vaccination Hesitancy: A Viewpoint. Vaccines, 11(7), 1191. [CrossRef]
- Tang, M.Y.; Rhodes, S.; Powell, R.; McGowan, L.; Howarth, E.; Brown, B.; Cotterill, S. (2021). How effective are social norms interventions in changing the clinical behaviours of healthcare workers? A systematic review and meta-analysis. Implementation Science, 16(1). [CrossRef]
- Christakis, N.A.; Fowler, J.H. (2012). Social contagion theory: examining dynamic social networks and human behavior. Statistics in Medicine, 32(4), 556–577. [CrossRef]
- Misra, R.; Kirk, B.; Shawley-Brzoska, S.; Totzkay, D.; Morton, C.; Kuhn, S.; Harris, M.; McMillion, M.; Darling, E. (2024). Educational Intervention to Increase COVID-19 Vaccine Uptake in Rural Patients with Chronic Diseases: Lessons Learned from An Innovative Academic–Community Partnership. International Journal of Environmental Research and Public Health/International Journal of Environmental Research and Public Health, 21(1), 71. [CrossRef]
- Takagi, M.A.; Hess, S.; Smith, Z.; Gawronski, K.; Kumar, A.; Horsley, J.; Haddad, N.; Noveloso, B.; Zyzanski, S.; Ragina, N. (2023). The impact of educational interventions on COVID-19 and vaccination attitudes among patients in Michigan: A prospective study. Frontiers in Public Health, 11. [CrossRef]
- Pierz, A.J.; Rauh, L.; Masoud, D.; Cruz, A.K.; Palmedo, P.C.; Ratzan, S.C.; Parker, R. (2023). Supporting US healthcare providers for successful vaccine communication. BMC Health Services Research, 23(1). [CrossRef]
- Ndasauka, Y.; Twabi, H.S.; Kainja, J.; Gunde, A.M.; Makhumula-Mtimuni, C. (2024). Knowledge, attitudes and demographic drivers for COVID-19 vaccine hesitancy in Malawi. Scientific Reports, 14(1). [CrossRef]
- Chen, Y.; Tower, M.; Zimmerman, P.A.; Layh, J.; Sparke, V.; Prichard, R.; Mason, M.; Lin, F.F. (2024). Perceptions and attitudes toward COVID-19 vaccination among health professional students in Australia: a qualitative study. Journal of Public Health Policy. [CrossRef]
- Karashiali, C.; Konstantinou, P.; Christodoulou, A.; Kyprianidou, M.; Nicolaou, C.; Karekla, M.; Middleton, N.; Kassianos, A.P. (2023). A qualitative study exploring the social contagion of attitudes and uptake of COVID-19 vaccinations. Human Vaccines & Immunotherapeutics, 19(2). [CrossRef]
- Wróblewski, M.; Meler, A.; Stankowska, J.; Kawiak-Jawor, E. (2022). An Analysis of Factors Shaping Vaccine Attitudes and Behaviours in a Low-Trust Society Based on Structural Equation Modelling—The Case of Poland’s Vaccination Programme against COVID-19. International Journal of Environmental Research and Public Health/International Journal of Environmental Research and Public Health, 19(22), 14655. [CrossRef]
- Rodrigues, F.; Ziade, N.; Jatuworapruk, K.; Caballero-Uribe, C.V.; Khursheed, T.; Gupta, L. (2023). The Impact of Social Media on Vaccination: A Narrative Review. Journal of Korean Medical Science/Journal of Korean Medical Science, 38(40). [CrossRef]
- Keselman, A.; Smith, C.A.; Wilson, A.J.; Leroy, G.; Kaufman, D.R. (2022). Cognitive and Cultural Factors That Affect General Vaccination and COVID-19 Vaccination Attitudes. Vaccines, 11(1), 94. [CrossRef]
- Rogers, A.A.; Cook, R.E.; Button, J.A. (2021). Parent and Peer Norms are Unique Correlates of COVID-19 Vaccine Intentions in a Diverse Sample of U.S. Adolescents. Journal of Adolescent Health, 69(6), 910–916. [CrossRef]
- Wollburg, P.; Markhof, Y.; Kanyanda, S.; Zezza, A. (2023). Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa. Communications Medicine, 3(1). [CrossRef]
- Galagali, P.M.; Kinikar, A.A.; Kumar, V.S. (2022). Vaccine Hesitancy: Obstacles and Challenges. Current Pediatrics Reports, 10(4), 241–248. [CrossRef]
- Ali GG, M.N.; Rahman, M.M.; Hossain, M.A.; Rahman, M.S.; Paul, K.C.; Thill, J.C.; Samuel, J. (2021). Public Perceptions of COVID-19 Vaccines: Policy Implications from US Spatiotemporal Sentiment Analytics. Healthcare, 9(9), 1110. [CrossRef]
- Phadke, V.K.; Bednarczyk, R.A.; Salmon, D.A.; Omer, S.B. (2016). Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States. JAMA, 315(11), 1149. [CrossRef]
- McKee, C.; Bohannon, K. (2016). Exploring the Reasons Behind Parental Refusal of Vaccines. the Journal of Pediatric Pharmacology and Therapeutics, 21(2), 104–109. [CrossRef]
- Shen, A.K.; Browne, S.; Srivastava, T.; Kornides, M.L.; Tan, A.S. (2023). Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizations. Vaccine, 41(12), 1994–2002. [CrossRef]
- How to talk about vaccines. (2021, May 19). https://www.who.int/news-room/feature-stories/detail/how-to-talk-about-vaccines.
- Kaufman, J.; Ryan, R.; Walsh, L.; Horey, D.; Leask, J.; Robinson, P.; Hill, S. (2018). Face-to-face interventions for informing or educating parents about early childhood vaccination. Cochrane Library, 2018(5). [CrossRef]
- Geoghegan, S.; O’Callaghan, K.P.; Offit, P.A. (2020). Vaccine Safety: Myths and Misinformation. Frontiers in Microbiology, 11. [CrossRef]
- Sinuraya, R.K.; Nuwarda, R.F.; Postma, M.J.; Suwantika, A.A. (2024b). Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia. Globalization and Health, 20(1). [CrossRef]
- Vilar-Lluch, S.; McClaughlin, E.; Knight, D.; Adolphs, S.; Nichele, E. (2023). The language of vaccination campaigns during COVID-19. Medical Humanities, 49(3), 487–496. [CrossRef]
- Personal Stories - Vaccinate Your Family. (2023, November 15). Vaccinate Your Family. https://vaccinateyourfamily.org/why-vaccinate/personal-stories/.
- Eguavoen, A.; Larson, H.; Chinye-Nwoko, F.; Ojeniyi, T. (2023). Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria. J. Public Health Africa (Online);14(5): 1-12, 2023. | AIM. https://search.bvsalud.org/gim/resource/es/biblio-1435811.
- Leibowitz, A.; Livaditis, L.; Daftary, G.; Pelton-Cairns, L.; Regis, C.; Taveras, E. (2021). Using mobile clinics to deliver care to difficult-to-reach populations: A COVID-19 practice we should keep. Preventive Medicine Reports, 24, 101551. [CrossRef]
- Relentless for an assured future for girls. (n.d.). UNICEF Nigeria. https://www.unicef.org/nigeria/stories/relentless-assured-future-girls/.
- Soni, G.K.; Bhatnagar, A.; Gupta, A.; Kumari, A.; Arora, S.; Seth, S.; Rastogi, A.; Kanagat, N.; Fields, R. (2023). Engaging Faith-Based Organizations for Promoting the Uptake of COVID-19 Vaccine in India: A Case Study of a Multi-Faith Society. Vaccines, 11(4), 837. [CrossRef]
- Marcell, L.; Dokania, E.; Navia, I.; Baxter, C.; Crary, I.; Rutz, S.; Monteverde MJ, S.; Simlai, S.; Hernandez, C.; Huebner, E.M.; Sanchez, M.; Cox, E.; Stonehill, A.; Koltai, K.; Waldorf KM, A. (2022b). One Vax Two Lives: a social media campaign and research program to address COVID-19 vaccine hesitancy in pregnancy. American Journal of Obstetrics and Gynecology, 227(5), 685-695.e2. [CrossRef]
- Steffens, M.S.; Dunn, A.G.; Leask, J.; Wiley, K.E. (2020). Using social media for vaccination promotion: Practices and challenges. Digital Health, 6, 205520762097078. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).